Position : Company List ››Canada ›› Toronto Canada ›› Chemicals, Plastics, and Raw Materials ›› Pharmaceuticals

Otava Ltd.

Company Description

OTAVA Ltd. is an international science-based chemical company founded in 1997. It has production laboratories and offices in Europe (Kiev, Ukraine) and North America (Toronto, Canada).

Our company carries a diverse set of products and services for pharmaceutical companies, universities, research institutes and government agencies. We specialize in the development and production of building blocks, screening compounds, fluorescent dyes and kinase-related products, including various inhibitors and kinase focused libraries.

Our facilities and highly-experienced personnel make possible a variety of contract research projects and custom syntheses of complex biologically active substances. Our Molecular Modeling Department provides a full range of advanced computational services.
- OTAVA, Ltd. offers wide range of target-focused libraries. These libraries are created on the base of extensive stock collection of 490,000 compounds. All the libraries are available on request.

- We offer a set of target-focused libraries with Enhanced Intellectual Property Potential. This set of libraries with a variety of novel compounds is an excellent starting point for research chemists and biologists in drug discovery. Screening compounds in these libraries are available from OTAVA Ltd. only and they are not distributed by other vendors of organic compounds.

- We sell potent and selective inhibitors of IKK-epsylon, SIRT1, SIRT2, STAT3, CK2, JNK3, GSK-3, CDK9, HDAC, HIF-1, eEF-2 kinases, CFTR chloride channel & MORE. These compounds are available in milligram and gram quantities. We also sell intermediates on route to the synthesis of these compounds.

- Our company offers about 475,000 Building Blocks in multi-gram quantities and purity higher than 95%. These diverse compounds could be used for high-throughput and combinatorial synthesis of pharmaceutical libraries or scale-up of lead compounds for further development.
- Our In-house Stock Collection contains more than 150,000 compounds and all the compounds have undergone quality control to confirm their chemical structures. All compounds are for prompt delivery.
- About 200,000 compounds are available from our Tangible Compounds collection. External compound suppliers are the main source of Tangible Compounds. ANY compound ordered from this library can be delivered in about 2-4 weeks. This is a unique opportunity to enrich your company's collection of compounds for screening purposes.

Company Information

Contact info

Related Product

Canada Pharmaceuticals Related Company

Relevant Companies

Categories